Guy A. M. Berbers

9.6k total citations
204 papers, 6.6k citations indexed

About

Guy A. M. Berbers is a scholar working on Epidemiology, Microbiology and Infectious Diseases. According to data from OpenAlex, Guy A. M. Berbers has authored 204 papers receiving a total of 6.6k indexed citations (citations by other indexed papers that have themselves been cited), including 149 papers in Epidemiology, 107 papers in Microbiology and 37 papers in Infectious Diseases. Recurrent topics in Guy A. M. Berbers's work include Bacterial Infections and Vaccines (105 papers), Pneumonia and Respiratory Infections (94 papers) and Respiratory viral infections research (48 papers). Guy A. M. Berbers is often cited by papers focused on Bacterial Infections and Vaccines (105 papers), Pneumonia and Respiratory Infections (94 papers) and Respiratory viral infections research (48 papers). Guy A. M. Berbers collaborates with scholars based in Netherlands, United Kingdom and United States. Guy A. M. Berbers's co-authors include Fiona van der Klis, Elisabeth A. M. Sanders, Pieter G. M. van Gageldonk, Frits R. Mooi, Liesbeth Mollema, Anne‐Marie Buisman, Hester E. de Melker, M.A.E. Conyn-van Spaendonck, Rutger M. Schepp and H. Bloemendal and has published in prestigious journals such as Proceedings of the National Academy of Sciences, The Lancet and JAMA.

In The Last Decade

Guy A. M. Berbers

202 papers receiving 6.4k citations

Peers

Countries citing papers authored by Guy A. M. Berbers

Since Specialization

Citations

This map shows the geographic impact of Guy A. M. Berbers's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Guy A. M. Berbers with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Guy A. M. Berbers more than expected).

Fields of papers citing papers by Guy A. M. Berbers

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Guy A. M. Berbers. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Guy A. M. Berbers. The network helps show where Guy A. M. Berbers may publish in the future.

Co-authorship network of co-authors of Guy A. M. Berbers

This figure shows the co-authorship network connecting the top 25 collaborators of Guy A. M. Berbers. A scholar is included among the top collaborators of Guy A. M. Berbers based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Guy A. M. Berbers. Guy A. M. Berbers is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Evaluation of Acute and Convalescent Antibody Concentration Against Pneumococcal Capsular Polysaccharides for the Diagnosis of Pneumococcal Infection in Children with Community-Acquired Pneumonia 2024 ·The Pediatric Infectious Disease Journal ·Michael J. Carter, Sonu Shrestha, Peter O’Reilly, (unknown), Meeru Gurung, Stephen Thorson, Rama Kandasamy, Merryn Voysey, (unknown), Sarah Kelly, (unknown), (unknown), Puja Amatya, Irina Tcherniaeva, Guy A. M. Berbers, David R. Murdoch, Andrew J. Pollard, Shrijana Shrestha, Dominic F. Kelly, (unknown)	0
2	Effect of Palivizumab Prophylaxis on Respiratory Syncytial Virus Infection in Very Preterm Infants in the First Year of Life in The Netherlands 2023 ·Vaccines ·Rutger M. Schepp, Joanna Kaczorowska, Pieter G. M. van Gageldonk, (unknown), Elisabeth A. M. Sanders, Patricia Bruijning‐Verhagen, Guy A. M. Berbers	2
3	Age and Primary Vaccination Background Influence the Plasma Cell Response to Pertussis Booster Vaccination 2022 ·Vaccines ·(unknown), (unknown), Cristina Teodósio, (unknown), (unknown), Anne‐Marie Buisman, (unknown), Martín Pérez‐Andrés, Alberto Órfão, Guy A. M. Berbers, Jacques J. M. van Dongen, Magdalena A. Berkowska	16
4	EULAR/PRES recommendations for vaccination of paediatric patients with autoimmune inflammatory rheumatic diseases: update 2021 2022 ·Annals of the Rheumatic Diseases ·Marc H.A. Jansen, Christien Rondaan, G. Elizabeth Legger, Kirsten Minden, Yosef Uziel, Nataša Toplak, Despoina Maritsi, (unknown), Guy A. M. Berbers, (unknown), (unknown), (unknown), Marc Bijl, Helen Foster, Isabelle Koné‐Paut, Carine Wouters, Angelo Ravelli, Ori Elkayam, (unknown), Marloes W Heijstek	38
5	Long-Term Immunogenicity upon Pertussis Booster Vaccination in Young Adults and Children in Relation to Priming Vaccinations in Infancy 2022 ·Vaccines ·(unknown), (unknown), Pieter G. M. van Gageldonk, (unknown), Lotte H. Hendrikx, Elisabeth A. M. Sanders, Guy A. M. Berbers, Anne‐Marie Buisman	1
6	Sex-Related Differences in the Immune Response to Meningococcal Vaccinations During Adolescence 2022 ·Frontiers in Public Health ·(unknown), Anna G. C. Boef, Susanne P. Stoof, (unknown), Fiona van der Klis, Guy A. M. Berbers, Mirjam J. Knol	3
7	Memory B Cell Activation Induced by Pertussis Booster Vaccination in Four Age Groups of Three Countries 2022 ·Frontiers in Immunology ·(unknown), Alex‐Mikael Barkoff, Marta Valente Pinto, (unknown), (unknown), Sagida Bibi, (unknown), Johanna Teräsjärvi, Katherine Sanders, (unknown), Raakel Luoto, (unknown), Elizabeth Clutterbuck, Elisabeth A. M. Sanders, Jussi Mertsola, Guy A. M. Berbers, Qiushui He, Dominic F. Kelly, Anne‐Marie Buisman	11
8	Population-based serology reveals risk factors for RSV infection in children younger than 5 years 2021 ·Scientific Reports ·Stijn P. Andeweg, Rutger M. Schepp, Jan van de Kassteele, Liesbeth Mollema, Guy A. M. Berbers, Michiel van Boven	58
9	Serotype-Specific IgG Antibody Waning after Pneumococcal Conjugate Primary Series Vaccinations with either the 10-Valent or the 13-Valent Vaccine 2018 ·Vaccines ·(unknown), Mirjam J. Knol, Alienke J. Wijmenga‐Monsuur, Irina Tcherniaeva, Leo M. Schouls, Elisabeth A. M. Sanders, Cécile A. C. M. van, Guy A. M. Berbers, Nynke Y. Rots	10
10	Differences by sex in IgG levels following infant and childhood vaccinations: An individual participant data meta-analysis of vaccination studies 2017 ·Vaccine ·Anna G. C. Boef, Fiona van der Klis, Guy A. M. Berbers, Anne‐Marie Buisman, Elisabeth A. M. Sanders, Jeanet M. Kemmeren, Arie van der Ende, Hester E. de Melker, Nynke Y. Rots, Mirjam J. Knol	11
11	Direct Comparison of Immunogenicity Induced by 10- or 13-Valent Pneumococcal Conjugate Vaccine around the 11-Month Booster in Dutch Infants 2015 ·PLoS ONE ·Alienke J. Wijmenga‐Monsuur, (unknown), Mirjam J. Knol, (unknown), Marta Zancolli, David Goldblatt, Pieter G. M. van Gageldonk, Irina Tcherniaeva, Guy A. M. Berbers, Nynke Y. Rots	28
12	Salivary antibody levels in adolescents in response to a meningococcal serogroup C conjugate booster vaccination nine years after priming: systemically induced local immunity and saliva as potential surveillance tool 2015 ·Vaccine ·Susanne P. Stoof, Fiona van der Klis, (unknown), Debby Bogaert, Krzysztof Trzciński, Elisabeth A. M. Sanders, Guy A. M. Berbers	14
13	Recombinant hybrid proteins from pertactin type 1 and 2 of Bordetella pertussis are more immunogenic in mice than the original molecules 2014 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Yassel Ramos, Glay Chinea, Guy A. M. Berbers, Gerardo Guillén	2
14	Waning of Maternal Antibodies Against Measles, Mumps, Rubella, and Varicella in Communities With Contrasting Vaccination Coverage 2013 ·The Journal of Infectious Diseases ·Sandra Waaijenborg, Susan Hahné, Liesbeth Mollema, Gaby Smits, Guy A. M. Berbers, Fiona van der Klis, H.E. de Melker, Jacco Wallinga	120
15	Immunogenicity and safety of the bivalent HPV vaccine in female patients with juvenile idiopathic arthritis: a prospective controlled observational cohort study 2013 ·Annals of the Rheumatic Diseases ·Marloes W Heijstek, Mirte Scherpenisse, Noortje Groot, Carline E. Tacke, Rutger M. Schepp, Anne‐Marie Buisman, Guy A. M. Berbers, Fiona van der Klis, Nico Wulffraat	43
16	Immunogenicity of a hexavalent vaccine co-administered with 7-valent pneumococcal conjugate vaccine. Findings from the National Immunisation Programme in the Netherlands 2012 ·Human Vaccines & Immunotherapeutics ·Jane Whelan, Susan Hahné, Guy A. M. Berbers, Fiona van der Klis, (unknown), Hein J. Boot	7
17	Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study 2011 ·Annals of the Rheumatic Diseases ·Marloes W Heijstek, Pieter G. M. van Gageldonk, Guy A. M. Berbers, Nico Wulffraat	52
18	Antibody responses to defined regions of theBordetella pertussisvirulence factor pertactin 2008 ·Scandinavian Journal of Infectious Diseases ·Marcel Hijnen, Qiushui He, Rutger M. Schepp, Pieter G. M. van Gageldonk, Jussi Mertsola, Frits R. Mooi, Guy A. M. Berbers	11
19	The role of peptide loops of the Bordetella pertussis protein P.69 pertactin in antibody recognition 2007 ·Vaccine ·Marcel Hijnen, Richarda M. de Voer, Frits R. Mooi, Rutger M. Schepp, Ed E. Moret, Pieter G. M. van Gageldonk, Gaby Smits, Guy A. M. Berbers	19
20	Antibodies to a new linear site at the topographical or functional interface between the haemagglutinin and fusion proteins protect against measles encephalitis. 1997 ·Journal of General Virology ·Philippe Fournier, G. Jung, Guy A. M. Berbers, F Schneider, Nicolaas H. C. Brons, Bernhard Fleckenstein, Claude P. Muller, (unknown)	56

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact